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Abstract: PURPOSE Left ventricular non-compaction (LVNC) is characterized by a 2-layered my-
ocardium composed of a noncompacted (NC) and a compacted (C) layer. The echocardiographic NC:C
ratio is difficult to assess in many patients. The aim of the study was to assess the value of cardiac com-
puted tomography (CCT) for the diagnosis of LVNC. METHODS In this prospective controlled study,
segmental analysis of transthoracic echocardiography (TTE) and prospective ECG-triggered CCT was
performed in 17 patients with LVNC and 19 healthy controls. In TTE maximal NC and C thickness was
measured at enddiastole and endsystole in the segment with most prominent trabeculation in short axis
views. In CCT, maximal segmental NC and C thickness was measured during diastole, and NC:C ra-
tio was determined. Spearman’s correlation coefficient and receiver operating characteristic curves were
calculated. RESULTS The median [IQR] radiation dose was 1.3[1.2-1.5]mSv. The CCT thickness of
the C layer was significantly lower in patients with LVNC as compared to controls in the inferolateral,
midventricular, lateral-, inferior-, and septal-apical segments. The CCT NC:C ratio differed significantly
between LVNC and controls in the inferior-midventricular and all the apical segments. NC:C ratio cor-
related significantly between TTE and CCT at enddiastole (฀ = 0.8) and endsystole (฀ = 0.9). Using a
CCT NC:C ratio ฀1.8, all LVNC patients could be identified. CONCLUSION LVNC can be diagnosed
with ECG-triggered low-dose CCT and discriminated from normal individuals using a NC:C ratio of ฀1.8
in diastole. There is a very good correlation of NC:C ratio in TTE and CCT.
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Left ventricular non-compaction (LVNC) is characterized by a 2-layered myocardium com-
posed of a noncompacted (NC) and a compacted (C) layer. The echocardiographic NC:C
ratio is difficult to assess in many patients. The aim of the study was to assess the value of
cardiac computed tomography (CCT) for the diagnosis of LVNC.
Methods
In this prospective controlled study, segmental analysis of transthoracic echocardiography
(TTE) and prospective ECG-triggered CCT was performed in 17 patients with LVNC and 19
healthy controls. In TTE maximal NC and C thickness was measured at enddiastole and
endsystole in the segment with most prominent trabeculation in short axis views. In CCT,
maximal segmental NC and C thickness was measured during diastole, and NC:C ratio was
determined. Spearman’s correlation coefficient and receiver operating characteristic curves
were calculated.
Results
The median [IQR] radiation dose was 1.3[1.2–1.5]mSv. The CCT thickness of the C layer
was significantly lower in patients with LVNC as compared to controls in the inferolateral,
midventricular, lateral-, inferior-, and septal-apical segments. The CCT NC:C ratio differed
significantly between LVNC and controls in the inferior-midventricular and all the apical seg-
ments. NC:C ratio correlated significantly between TTE and CCT at enddiastole (σ = 0.8)
and endsystole (σ = 0.9). Using a CCT NC:C ratio�1.8, all LVNC patients could be
identified.
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Conclusion
LVNC can be diagnosed with ECG-triggered low-dose CCT and discriminated from normal
individuals using a NC:C ratio of�1.8 in diastole. There is a very good correlation of NC:C
ratio in TTE and CCT.
Introduction
Isolated left ventricular noncompaction (LVNC) is characterized by a two-layered myocar-
dium consisting of a noncompacted (NC) and a compacted layer (C). Echocardiographic crite-
ria with a maximal endsystolic ratio of NC:C> 2 and deep intertrabecular recesses with a
predominant location in the apical segments and absence of coexisting cardiac abnormalities
have been established and validated against anatomical examination of the heart [1]. However,
these criteria are sometimes difficult to assess due to insufficient echocardiographic windows.
Complementary imaging modalities such as cardiac magnetic resonance (CMR) or cardiac
computed tomography (CCT) might overcome such limitations and provide an added diag-
nostic value.
CT offers a high spatial resolution and is independent of any acoustic window. Moreover,
the acquisition of three-dimensional datasets allows interpretation and measurements of any
angle post scanning. Additionally, technical refinements, such as prospective ECG-triggering
and iterative reconstruction algorithms have led to substantial radiation dose reduction [2, 3]
and have made CCT feasible with a radiation exposure< 1mSv. So far, only limited data with
small groups of patients are available regarding the diagnosis of LVNC in CCT and to our
knowledge, no study has investigated the feasibility to diagnose LVNC using low-dose pro-
spectively triggered CCT. Melendez-Ramirez et al. included 10 LVNC patients in their study
and patients were exposed to a high effective radiation exposure of 12 mSv [4]. The group of
Sidhu et al. investigated 8 patients with LVNC and used retrospective gating similar to the pre-
vious study [5]. In order to use CT as a complementary modality for diagnosis of LVNC, mor-
phological CCT criteria are crucial. Thus, it was the aim of the present prospective controlled
study to establish CCT criteria that distinguish LVNC from healthy controls by prospective
ECG-triggered low-dose CCT using TTE as the standard of reference.
Materials andmethods
Patient population
In this prospective controlled study, thirty-six patients were included to undergo TTE and pro-
spectively ECG-triggered low dose CCT at the University Hospital in Zurich. After screening
our database, 37 participants were recruited via phone call between October 2011 and Decem-
ber 2014. The final study population consisted of 19 healthy controls (volunteers who were
recruited via phone call) and 17 patients with definite diagnosis of LVNC (Fig 1). All these
individuals were Caucasians. Median [IQR] age was 54 [43–58] years, 24 (67%) were males,
and the median [IQR] BMI was 25 [23–27] kg/m2. The diagnosis of LVNC was established by
TTE with strict adherence to previously published criteria comprising the following four con-
ditions: (1) absence of coexisting cardiac abnormalities; (2) a two-layered myocardial wall with
a C subepicardial layer and a NC subendocardial layer, with a maximal end-systolic ratio of
NC:C> 2 in parasternal short-axis view; (3) a predominant mid-lateral, mid-inferior, and api-
cal location of affected segments; and (4) colour Doppler with adjustment of the colour scale
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for evidence of deep intertrabecular recesses filled with blood from the left ventricular cavity.
Additionally, compacted wall thickness� 8.1 mm was found to be very specific for myocardial
thickening in LVNC compared to normal controls [1, 6].
Patients with renal insufficiency (GFR<60ml/min; 2.5%), known allergy to iodinated con-
trast agent, known hyperthyroidism, non-sinus rhythm, high burden of premature ventricular
or supraventricular beats (> 10/min), or hypotension were excluded. Furthermore, patients
with any cardiac disease other than isolated LVNC were excluded. This study complies with
the declaration of Helsinki, the study protocol was approved by the local ethics committee
(Kantonale Ethikkommission Zürich), and was registered at ClinicalTrials.gov
(NCT01470014). Written informed consent was obtained from all patients.
Transthoracic echocardiography
TTE was performed using commercially available equipment (Siemens Medical Solutions
USA, Inc., Malvern, PA; Philips iE33, Philips Medical Systems, Andover, MA; and GE Vivid 7,
GE Healthcare, Milwaukee, WI). Images acquired in parasternal long-axis, parasternal short-
axis, and apical views were analysed offline on digitally stored loops.
In all participants, TTE analysis was performed by an experienced observer who deter-
mined wall thickness from digitally stored loops for this study blinded to the CCT. Each seg-
ment was analysed in standard parasternal short axis views (2D) regarding the presence of
LVNC. Maximal thickness of NC layer in LVNC patients or trabeculated layer in controls,
respectively, and maximal thickness of C layer were measured in the segment with most prom-
inent recesses (in LVNC) or trabeculations (in controls) at end-systole because the two layers
are then easier to distinguish and because the ratio of the two layers was established by a side-
by-side comparison of echocardiographic images with the corresponding pathologic speci-
mens as previously described [1]. Additionally, maximal thickness of NC and C layers was
Fig 1. Participant flow chart.
https://doi.org/10.1371/journal.pone.0235751.g001
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measured in end-diastole in these segments. At the midventricular level, segments with papil-
lary muscles were not used for measurements to avoid any confounding effects. The ratio of
maximal thickness of NC and C was calculated. To facilitate reading, both the NC layer in
patients with LVNC and the trabeculated layer in controls will be called ‘‘noncompacta”
throughout the text, while both the compacted layer in patients with LVNC and the nontrabe-
culated layer in controls will be called ‘‘compacta” throughout the text. Each echo and mea-
surement were performed by two observers in consensus. One of these observers was an
experienced imaging specialist for all the examinations.
Cardiac computed tomography
Prior to the CCT examination metoprolol (AstraZeneca, London, UK) up to 20mg was
injected intravenously if heart rate was higher than 65 beats per minute in order to obtain
optimal image quality for CCT. All patients underwent contrast-enhanced CCT during
inspiration breath hold with prospective ECG-triggering as previously reported on a 64-slice
CT scanner (Discovery CT 750 High Definition; GE Healthcare, Milwaukee, WI, USA; Fig
2). By choosing the smallest possible window at only one distinct end-diastolic phase of the
RR-cycle (i.e. 75%), we ascertained the lowest achievable effective dose delivery, using a com-
mercially available protocol (SnapShot Pulse, GE Healthcare). [3, 7]. Iodixanol (Visipaque
320, 320 mg/ml, GE Healthcare) was injected into an antecubital vein followed by 50 ml
saline solution. Contrast media volume (40–105 ml) and flow rate (3.5–5 ml/s) were adapted
to body surface area (BSA) as previously validated [8]. Scanning parameters were as follows:
Collimation of 64 x 0.625 mm, gantry rotation time of 0.35 s and field of view was 25 cm.
Tube voltage (100–120 kV) and tube current (450–700 mA) were adapted to body mass
index as previously described [7, 9]. Effective radiation dose from CCTA was calculated as
the product of dose-length product (DLP) times a conversion coefficient for chest (k = 0.014
mSv mGy-1 cm-1) [10].
All images were transferred to an external workstation (AW 4.6, GE Healthcare) for analy-
sis. Measurements were performed by an experienced CCT reader, blinded to echocardio-
graphic results. Cardiac planes were obtained at short axis views (basal, midventricular and
apical), and long axis views (two-, three, and four-chamber view). The 17-segment model was
used as proposed by the American Heart Association, and the European Association of Car-
diovascular Imaging [11, 12]. Maximal thickness of C and NC layer was measured in each seg-
ment in short axis views (basal, midventricular and apical) and the ratio of NC: C was
calculated. At the midventricular level, papillary muscles were carefully tracked in order to
avoid any confounding effects. The apex (segment 17) was excluded from the analysis because
this segment would exhibit an artificially high NC: C ratio due to a thin C and a thick NC
layer, as previously suggested [4].
Statistical analysis
Quantitative variables were expressed as mean±standard deviation or median and interquartile
range [IQR]. The statistical software package SPSS 20.0 (SPSS, Chicago, IL) was used for analy-
sis. Segmental CCT NC:C ratio was calculated and compared between LVNC and control.
Intra and inter-rater agreement for the CCT based assessment of NC:C ratio were measured
using Bland Altmann analysis for each segment in a representative sample of 12 patients (6 NC
and 6 controls). The mean difference (bias) and Bland-Altman (BA) limits of agreement (i.e.,
mean ± 1.96 SD) were calculated. The data were tested for normal distribution by Shapiro-
Wilk test. Comparison of variables with no normal distribution was performed with Mann-
Whitney U Test. Spearman’s correlation coefficient was calculated between TTE and CCT
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segmental ratios and BA limits of agreement were calculated. Receiver operating characteristic
curves were used to generate cut-off values for distinguishing LVNC from control on a per-
segment and a per-patient basis. The optimal cut-point were determined by the Youden-
Index. Patients with at least one segment fulfilling the established cut-off value were consid-
ered as LVNC patients. P values of less than 0.05 were considered statistically significant. A
sample size of 411 segments was calculated in order to provide a desired precision of 6%.
Fig 2. TTE and contrast enhanced CCT. Basal, midventricular and apical short axis and three-chamber view of a
patient with isolated LVNC acquired by transthoracic echocardiography and prospectively ECG-triggered low dose
CCT.
https://doi.org/10.1371/journal.pone.0235751.g002
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Results
A total of 17 patients with LVNC and 19 controls underwent low-dose CCT without any
adverse events and were included in the final analysis. Previous to CCT the patients received 3
[0–10] mg metoprolol and the median [IQR] radiation exposure of low-dose CCT was 1.3
[1.2–1.5] mSv. The median [IQR] heart rate during the scan was 56 [50–61] beats per minute.
Patient baseline characteristics of both groups are listed in Table 1.
Based on echocardiographic myocardial layer thickness (Table 2), the maximal myocardial
median [IQR] NC:C ratio for LVNC vs controls was 3.3 [2.5–4.3] vs 0.9 [0.6–1.1] (p<0.001)
during end-systole and 4.3 [3.1–5.1] vs 1.0 [0.8–1.5] (p<0.001) during end-diastole.
The CCT median value for maximal diastolic NC thickness per patient was significantly
higher in LVNC vs controls. This resulted in a significantly higher median NC:C ratio in
LVNC vs controls (Table 3). Intra- and inter-observer agreement for CCT based evaluation of
the NC:C ratio, was excellent with small bias and narrow BA limits of agreement (bias 0.016
and 0.001 with limits of agreement -0.21, +0.24 and -0.13 to +0.14, for inter-rater and intra-
rater agreement respectively).
There was a significant correlation of the NC:C ratio between CCT and TTE both at endsys-
tole (σ = 0.9; p<0.001) with narrow Bland-Altman limits of agreement (-2.6 to 1.0) and at end-
diastole (σ = 0.8; p<0.001) with broader Bland-Altman limits of agreement (-4.4 to 1.8) (Fig 3).
Table 1. Patient baseline characteristics.
LVNC Control
Number (n) 17 19 p = 0.74
Age (years) 53 [41–62] 54 [49–58] p = 0.96
Male (%) 71 63 p = 0.046
Smoking (%) 24 26 p = 0.003
Hypertension (%) 23 5 p< 0.001
Dyslipidaemia (%) 18 16 p< 0.001
Diabetes (%) 6 11 p< 0.001
Family History of LVNC or SCD 47 0 p< 0.001
CRT-D or ICD 29 0 p< 0.001
Oral anticoagulation 47 0 p< 0.001
BSA (m2) 1.8 [1.6–2.0] 1.9 [1.8–2.0] p = 0.12
BMI (kg/m2) 24 [21–25] 25 [24–27] p = 0.32
Contrast media (ml) 70 [60–80] 60 [60–80] p = 0.64
CCT radiation dose (mSv) 1.3 [1.2–1.5] 1.4 [1.2–1.6] p = 0.48
LVEF (%) 52 [44–57] 59 [57–63] p = 0.002
LVESV (ml) 51 [39–72] 43 [34–47] p = 0.05
LVEDV (ml) 104 [88–143] 105 [92–116] p = 0.70
LVEDD (mm) 51 [48–58] 48 [47–52] p = 0.02
LVESD (mm) 35 [33–39] 31 [27–32] p< 0.001
RV Area D (cm2) 17 [15–21] 19 [15–20] p = 0.76
TAPSE (mm) 22 [19–25] 22 [18–23] p = 0.33
FAC (%) 43 [38–47] 42 [39–43] p = 0.56
Data are given in median [IQR] were appropriate. LVEF = left ventricular ejection fraction; LVESV = left ventricular
end-systolic volume; LVEDV = left ventricular end-diastolic volume; LVEDD = left ventricle end-diastolic diameter;
LVESD = left ventricle end-systolic diameter; RV = right ventricle; TAPSE = Tricuspid annular plane systolic
excursion; FAC = fractional area change. D = Diastole. LVNC = left ventricular non-compaction, SCD = sudden
cardiac death; CRT = Cardiac resynchronization therapy; ICD = implantable cardiac defibrillator.
https://doi.org/10.1371/journal.pone.0235751.t001
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The CCT segmental median [IQR] thickness of the C layer was significantly lower in LVNC
compared to controls in the inferolateral-midventricular (7.8 [6.8–9.8] mm vs 8.8 [7.8–9.5]
mm), lateral-apical (6.2 [5.9–8.0] mm vs 8.3 [7.5–9.3] mm), inferior-apical (6.3 [5.7–6.7] mm
vs 7.8 [6.9–8.4] mm), and septal-apical (6.9 [6.0–7.5] mm vs 7.9 [7.2–8.8] mm) segments,
whereas it did not differ significantly in the remaining segments (Fig 4A).
The CCT segmental median [IQR] thickness of the NC layer was significantly higher in
LVNC compared to controls in the inferior-midventricular (7.6 [0–12.9] mm vs 0 [0–0] mm),
anterior-apical (12.4 [3.1–14.2] mm vs 6.2 [0–8.2] mm), septal-apical (7.3 [0–13.1] mm vs 0
[0–0] mm), and inferior-apical (12.9 [11.1–15.3] mm vs 3.2 [0–8.2] mm), and lateral-apical
(13.1 [11.3–15.0] mm vs 7.7 [4.9–8.4] mm), segments, whereas it did not differ significantly in
the remaining segments (Fig 4B).
The CCT median NC:C ratio differed significantly between LVNC and controls in the infe-
rior-midventricular (0.9 [0–2.1] vs 0 [0–0]), lateral-apical (2.1 [1.8–2.3] vs 0.8 [0.6–1.1]), infe-
rior-apical (2.2 [1.8–2.5] vs 0.4 [0.0–1.0]), septal-apical (1.1 [0–2.1] vs 0 [0–0]), and anterior-
apical (1.6 [0.3–2.1] vs 0.8 [0–1.0]) segments (Fig 4C). Accordingly, the inferior-apical segment
exhibited the most prominent trabeculations in both TTE and CCT as it represented maximal
trabeculation in 72% and 44% of the patients, respectively (Fig 4D).
Based on echocardiography, 54 affected segments were identified in the 17 LVNC patients
and 0 affected segments in the 19 controls, respectively. The quantitative segmental NC:C
CCT analysis revealed a optimal cut-off value of�1.8 for detecting an affected LVNC segment
with an area under the curve of 0.997 (Fig 5).
Discussion
This study demonstrates the feasibility to diagnose LVNC with prospective ECG triggered
low-dose CCT in a prospective controlled trial with a median [IQR] radiation dose of 1.3 [1.2–
1.5] mSv.
Table 2. Echocardiographic myocardial layer thickness.
Echocardiographic median [IQR] myocardial layer thickness (mm) LVNC Controls p value
NC (end-systolic) 15.0 [12–16.5] 7 [6–9] p < 0.001
C (end-systolic) 5.0 [3.5–5] 9 [7–10] p < 0.001
NC:C ratio (end-systolic) 3.3 [2.5–4.3] 0.9 [0.6–1.1] p < 0.001
NC (end-diastolic) 14.0 [12.5–16] 6 [5–9] p < 0.001
C (end-diastolic) 3.0 [3.0–4.5] 6 [5–7] p < 0.001
NC:C (end-diastolic) 4.3 [3.1–5.1] 1 [0.8–1.5] p < 0.001
Echocardiographic median [IQR] myocardial layer thickness (mm) of the segment with maximal values per patient for end-systole and end-diastole. NC: non-compacta,
C: compacta.
https://doi.org/10.1371/journal.pone.0235751.t002
Table 3. CCTmyocardial layer thickness.
CCT median [IQR] myocardial layer thickness (mm) LVNC Controls p value
NC 12.9 [11.4–15.3] 4.5 [0–9.3] p < 0.001
C 6.3 [5.8–6.7] 7.8 [6.9–8.1] p = 0.001
NC:C ratio 2.2 [1.8–2.4] 0.7 [0–1.1] p < 0.001
CCT median [IQR] myocardial layer thickness (mm) of the segment with maximal values per patient. NC: non-
compacta, C: compacta.
https://doi.org/10.1371/journal.pone.0235751.t003
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Since its first description by Engberding et al in 1984, LVNC has gained increasing atten-
tion [13]. Based on morphological criteria established for echocardiography [1, 14–16], it is
categorized as an unclassified cardiomyopathy by the European Society of Cardiology [17].
Accurate diagnosis of LVNC is essential as patients may suffer from complications such as
heart failure, ventricular arrhythmias, sudden cardiac death, and systemic embolic events [18].
Until now most accepted criteria are based on echocardiography; however, good image quality
is mandatory for applying these criteria because accurate measurements in parasternal short
axis views should only be performed with correct angulation. Oblique views will necessarily
lead to overestimation of myocardial wall thickness and possibly misinterpretation of images
resulting in a false diagnosis of LVNC. In this study, CCT short axis and long axis views were
used in order to (a) assess maximal thickness of the C and the NC layer and (b) carefully avoid
inccidental measurement of papillary muscles as part of the NC layer. While Sidhu et al used
Fig 3. Comparison of the NC:C ratio between CCT and TTE. Comparison between NC:C ratio between CCT and TTE reveal a significant correlation both at end-
systole (σ = 0.9; A) and end-diastole (σ = 0.8; C). Also Bland Altman limits of agreement are presented regarding the comparison of NC:C ratio for CCT and TTE at end-
systole (-2.6 to 1; B) and end-diastole (-4.4 to 1.8; D).
https://doi.org/10.1371/journal.pone.0235751.g003
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Fig 4. Polar plots. The polar plots are illustrating the median CCT segmental thickness of the C layer (mm) for the
control (left) and LVNC (right) group (A). Basal segments 1–6 are shown in the outer layer, midventricular segments
7–12 in the middle layer and apical segment 13–16 in the inner layer (counterclockwise). The CCT segmental median
PLOS ONE Cardiac computed tomography for left ventricular non-compaction
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long axis views only [5], the present study took full advantage of the strength of CCT which
consists of a three-dimensional dataset with high spatial resolution and allows post-processing
along any angulation including short axis views analogous to those generated by
echocardiography.
The low prevalence of LVNC indicated between 0.02% to 0.26% in adults [19–21] may have
contributed to the fact that so far only case reports [22–24] and two original articles with 8 and
10 LVNC patients, respectively, have investigated the accuracy of CCT in patients with this
cardiomyopathy [4, 5]. In the present study, we have prospectively enrolled a cohort of 36 indi-
viduals including 17 patients with previously diagnosed LVNC. The cut-off value of�1.8 to
distinguish normal from pathological myocardial segments was lower as compared to the pre-
vious studies reporting a cut-off value of� 2.2 for CCT [4, 5]. This might be related to the
observation that LVNC was analysed at a later stage of the disease in the previous studies
resulting in more dilated left ventricles [4, 5]. Howevere, left ventricular ejection fraction con-
tinuisly decreased in a substantial number of our participants and implantaple cardioverter
defibrillator or cardiac resynchronization therapy was necessary. Additionally, while both
Melendez et al [4] and Sidhu et al [5] acquired CCT with retrospective gating, we used pro-
spective ECG triggered CCT acquired in the 75% of the RR interval. Different phases might
thickness of the C layer was significantly lower in the LVNC group compared to controls in the inferolateral-
midventricular, lateral-, inferior-, and septal-apical segments (�), whereas it did not differ significantly in the
remaining segments. The polar plots are illustrating the median CCT segmental thickness of the NC layer (mm) for the
control (left) and LVNC (right) group (B). Basal segments 1–6 are shown in the outer layer, midventricular segments
7–12 in the middle layer and apical segment 13–16 in the inner layer (counterclockwise). The CCT segmental median
thickness of the NC layer was significantly higher in the LVNC group compared to controls in the inferoior-
midventricular, anterior-apical, septal-apical, and inferior-apical, and latero-apical, segments (�), whereas it did not
differ significantly in the remaining segments. The polar plots are illustrating the median CCT segmental NC:C ratio
for the control (left) and LVNC (right) group (C). Basal segments one to six are shown in the outer layer,
midventricular segments 7–12 in the middle layer and apical segment 13–16 in the inner layer (counterclockwise). The
median CCT NC:C ratio differed significantly between LVNC and controls in the inferior-midventricular, lateral-,
inferior-, septal-, and anterior-apical segments(�). The polar plots are illustrating the segments with maximal
trabecularisation (%) for CCT (left) and TTE (right) (D). Basal segments one to six are shown in the outer layer,
midventricular segments 7–12 in the middle layer and apical segment 13–16 in the inner layer (counterclockwise). The
inferior-apical segment exhibited the most prominent trabeculations in both TTE (72%) and CCT (44%).
https://doi.org/10.1371/journal.pone.0235751.g004
Fig 5. CCT NC:C ratio per patient and per segment.Using the NC:C threshold of�1.8 (horizontal line), CCT identified 55 LVNC segments in 17 patients. 3
segments were false positive, and 2 segments were false negative (A). Using this cut-off, all LVNC patients could be identified (B). ROC analysis of the quantitative
segmental NC:C CCT analysis revealed an area under the curve of 0.997 (C).
https://doi.org/10.1371/journal.pone.0235751.g005
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result in different C and NCmeasurement and different cut-off values. Furthermore, compara-
bility between the CCT derived NC:C thresholds from the former studies and our ratio might
be difficult due to the low number of patients included in the studies. Phenotypic variability
might indeed result in different CCT derived NC:C thresholds and a higher patient number
could overcome this issue. Our cohort included 36 patients including 17 patients with LVNC,
representing the largest CCT LVNC cohort so far. However, further studies are needed to
expand the patient number and confirm these observations.
A maximal endsystolic ratio of NC:C>2 has been established as one of the major criteria to
diagnose LVNC by TTE and validated versus anatomical examination of the heart [1]. Com-
pared to echocardiography, our CCT NC:C threshold of�1.8 NC:C is somewhat lower. How-
ever, different modalities provide different values due to different spatial resolution and the
differences in the techniques itself. Furthermore, in contrast to our measurements, which were
performed in diastole in short and long axis, Jenni et al measured the echocardiographic ratio
of NC:C in parasternal short axis views during end-systole because the two layers are easier to
distinguish by echocardiography in this phase of the cardiac cycle and because the ratio of the
two layers was established by a side-by-side comparison of echocardiographic images with the
corresponding pathologic specimens [1]. In contrast, Chin et al used the ratio of myocardial
thickness from the epicardial surface to through and epicardial surface to peak of the trabecu-
lation at end-diastole in parasternal long axis and four chamber view [14]. The phase of the
measurements in the studies by Stöllberger and Belanger is less well characterized [15, 16]. In
this study, we measured the NC:C ratio in echocardiography both at end-systole and end-dias-
tole and observed an excellent correlation of NC:C ratio obtained by CTA with both echocar-
diographic measurements. The correlation between diastolic NC:C ratio in CTA and end-
systolic NC:C ratio in echocardiography was higher than end-diastolic ratio in the latter
modality, which is possibly related to the better echocardiographic differentiation of the two
layers in end-systole.
Several different methods have been proposed to diagnose LVNC by CMR. Peterson et al
applied an end-diastolic NC:C Ratio�2.3 measured in long axis cine views at the site with
most pronounced trabeculations [25]. Stacey et al defined an end-systolic ratio�2 in short
axis views to diagnose LVNC [26]. Captur et al described an end-diastolic loss of the base to
apex fractal dimension gradient�1.3 for LVNC [27] and Jacquier used short axis views to
measure trabecular mass [28]. The fact that no single method has been asserted oneself sup-
ports the need of further modalities as well as additional criteria such as clinical and/or genetic
information. On the other hand additional information on fibrosis burden can be provided by
CMR which is crucial for arrhythmia risk stratification. Our CCT threshold differed from
CMR values. Differences in spatial resolution of the two modalities, measurements in long axis
versus short axis, and variability in the time frame of measurements might have contributed to
the different cut-off values.
Any diagnostic tool should offer a positive balance of harms and benefits. This is particu-
larly true for CCT, which has in the past evoked a vivid discussion on its potential carcinogenic
risk and its justification for a purely diagnostic test. Melendez-Ramirez et al and Sidhu et al
reported a high accuracy to detect LVNC in CCT; however, their CCT resulted in a high radia-
tion exposure for the patients of>12 mSv, whereas this value averaged 1.3 [1.2–1.5]mSv
despite high accuracy in our study. This was enabled by prospective ECG triggering, e.g. limit-
ing the beam to a narrow diastolic phase, and a BMI adapted scanning protocol, with adjective
tube current and voltage [3]. In fact, both previously published studies used only the diastolic
phase for diagnosis of LVNC despite scanning throughout the whole heart cycle. We have
demonstrated for the first time, that diagnosis of LVNC is feasible with prospectively ECG-
triggered CCT resulting in a low radiation dose.
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Based on our results CCT can be used complementary to previously established imaging
techniques. However, overdiagnosis of LVNC is an issue of concern. Zemrak et al demon-
strated in the MESA (Multi-Ethnic Study of Atherosclerosis) study that a huge number of
asymptomatic patients fulfilled the Peterson CMR criteria for LVNC without exhibiting any
adverse events [29]. This observation illustrates that additional criteria are essentially needed
in order to confirm the diagnosis of LVNC. Gebhard et al demonstrated that a maximal sys-
tolic C thickness<8 mm allows to differentiate LVNC from normal hearts and from hypertro-
phic ventricles as well using TTE [6]. The present results are in line with this observation as
the mean diastolic thickness of the C layer in CCT was significantly lower in patients with
LVNC in the inferolateral-midventricular as well as the lateral-, inferior- and septal-apical seg-
ments. Furthermore, the echocardiographic C layer thickened in end-systole as compared to
end-diastole in controls, whereas it did not in LVNC patients. On top of additional imaging
criteria, information such as genotype [30], evidence of LVNC related clinical events, and a
positive family history for LVNC or other cardiomyopathies should be included when LVNC
is diagnosed in an individual [31].
Recently, iodine staining enhanced micro CT enabled the differentiation between the NC
and C layer in mice with deletion of the cell cycle inhibitor protein p27Kip1 [32] and tissue
characterization might be feasible in the near future by the use of dual-source or single-source
dual energy techniques [7]. Hence, systematic clinical application of CCT for diagnosis of
LVNCmight become common practice in the future.
There are some potential limitations of this study. Despite the prospectively controlled
study design, the cohort size was small and the results were obtained in a single center. Multi-
center studies are thus needed to confirm the results in a larger and unselected population. In
this study, we have established the NC:C threshold only in LVNC patients versus healthy con-
trols. Thus, the applicability of the proposed criterion will have to be validated in the differenti-
ation of LVNC from other cardiac diseases such as patients with hypertrophic or dilated
cardiomyopathy. Furthermore, African-Americans and athletes were not included in the study
as it is known that they are more likely to fulfill the LVNC criteria. Finally, clinical history
regarding arrhythmia was not available.
To conclude, this study demonstrates that CCT allows to discriminate LVNC patients from
healthy persons with low radiation exposure. CCT might be used complementary to echocar-
diography in patients with equivocal results or poor image quality to provide further evidence
whether the patient is affected or not, particularly when there is an indication to exclude the
presence of coronary artery disease in such an individual. Furthermore, as patients undergo
CCT for other reasons, this threshold may be used for answering the question whether acci-
dentally seen trabeculations are consistent with the diagnosis of LVNC.
Supporting information
S1 Checklist. TREND checklist.
(PDF)
S1 File. Ethical protocol.
(DOC)
Acknowledgments
We thank our radiographers Thomas Berthold, Verna Weichselbaum, and Edlira Dauti-Loga
for their excellent technical support. This study was supported by the Swiss Heart Foundation.
PLOS ONE Cardiac computed tomography for left ventricular non-compaction
PLOSONE | https://doi.org/10.1371/journal.pone.0235751 July 10, 2020 12 / 15
Author Contributions
Conceptualization: Jelena R. Ghadri, Bernhard A. Herzog, Christiane Gruner, Philipp A.
Kaufmann, Felix C. Tanner.
Data curation: Tobias A. Fuchs, Ladina Erhart, Jelena R. Ghadri, Bernhard A. Herzog,
Andreas Giannopoulos.
Formal analysis: Tobias A. Fuchs, Andreas Giannopoulos.
Investigation: Tobias A. Fuchs, Ladina Erhart, Jelena R. Ghadri, Bernhard A. Herzog.
Methodology: Tobias A. Fuchs, Ladina Erhart, Jelena R. Ghadri, Bernhard A. Herzog, Ronny
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